Literature DB >> 7517864

Three-dimensional crystal structure of the A-tract DNA dodecamer d(CGCAAATTTGCG) complexed with the minor-groove-binding drug Hoechst 33258.

M C Vega1, I García Sáez, J Aymamí, R Eritja, G A Van der Marel, J H Van Boom, A Rich, M Coll.   

Abstract

The molecular structure of the DNA A-tract dodecamer d(CGCAAATTTGCG) complexed with the drug Hoechst 33258 has been determined by X-ray diffraction analysis. The Hoechst molecule binds in the DNA minor groove covering the sequence AATTT of the central A-tract, with the piperazine group close to one of the GC regions. The drug molecule makes two three-centered hydrogen bonds from the nitrogen atoms of the benzimidazole rings to the N3 and O2 atoms of the DNA bases. Although a high propeller twist is observed in the A-tract, only one unsymmetrical three-centered hydrogen bond is present in the DNA major groove. The structure is compared with other minor-groove-binding drug complexes and the influence of these drugs on DNA A-tracts is discussed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7517864     DOI： 10.1111/j.1432-1033.1994.tb18917.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN： 0014-2956


  24 in total

1.  Sequence-dependent variation in DNA minor groove width dictates orientational preference of Hoechst 33258 in A-tract recognition: solution NMR structure of the 2:1 complex with d(CTTTTGCAAAAG)(2).

Authors:  E Gavathiotis; G J Sharman; M S Searle
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Intact MutY and its catalytic domain differentially contact with A/8-oxoG-containing DNA.

Authors:  X Li; A L Lu
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

3.  Significance of ligand tails for interaction with the minor groove of B-DNA.

Authors:  B Wellenzohn; W Flader; R H Winger; A Hallbrucker; E Mayer; K R Liedl
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

4.  Sequence-specific minor groove binding by bis-benzimidazoles: water molecules in ligand recognition.

Authors:  Christian Bailly; Gianni Chessari; Carolina Carrasco; Alexandra Joubert; John Mann; W David Wilson; Stephen Neidle
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

5.  Ensemble and single-molecule fluorescence spectroscopic study of the binding modes of the bis-benzimidazole derivative Hoechst 33258 with DNA.

Authors:  Amitava Adhikary; Volker Buschmann; Christian Müller; Markus Sauer
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

6.  Structural insights into the effect of hydration and ions on A-tract DNA: a molecular dynamics study.

Authors:  A Madhumalar; Manju Bansal
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

7.  Electrostatic contributions to heat capacity changes of DNA-ligand binding.

Authors:  K Gallagher; K Sharp
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

8.  Designer DNA-binding drugs: the crystal structure of a meta-hydroxy analogue of Hoechst 33258 bound to d(CGCGAATTCGCG)2.

Authors:  G R Clark; C J Squire; E J Gray; W Leupin; S Neidle
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

9.  Variability in DNA minor groove width recognised by ligand binding: the crystal structure of a bis-benzimidazole compound bound to the DNA duplex d(CGCGAATTCGCG)2.

Authors:  A A Wood; C M Nunn; A Czarny; D W Boykin; S Neidle
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

10.  The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II.

Authors:  Brian B Hasinoff; Xing Wu; John L Nitiss; Ragu Kanagasabai; Jack C Yalowich
Journal:  Biochem Pharmacol       Date:  2012-10-05       Impact factor: 5.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.